Private equity firms Whitecap and M Ventures led a $14m Series A round in Altoida, a precision neurology company, with participation from HonorHealth, BTOV, Alpana Ventures, Hikma Ventures, Fyrfly and VI Partners. “We are pleased to have new investors join Altoida and to have our existing investors continue their support. Having both biotech and tech industry investors with complementary acumen, networks, and commitment to innovation in neurology will help enable us to bring our products to patients, providers, and researchers earlier. Our unique team of experts across neurology, machine learning, and digital biomarker science position us well to execute on our vision to deliver early and accurate brain health measurements and diagnostics to individuals across the world," Travis Bond, Altoida CEO.